The aim of this study was to evaluate the role of the hOGG1-Ser326Cys (rs13181), XRCC1-rs1799782;s746702110" genes_norm="4968;7515">Arg194Trp (rs1799782), and ERCC2-rs13181" genes_norm="2068">Lys751Gln (rs13181) gene polymorphisms with clinical parameters and the risk for development of triple-negative breast cancer.